Share on social media
24 November 2015
We are pleased to bring you the latest edition of our Newsletter written by our professionals to bring you up to date with important topics in Intellectual Property.
In this issue we report on developments in the area of human embryonic stem cell patenting with the CJEU decision on parthenotes, and on the decision from the EPO Enlarged Board of Appeal on the Tomatoes II and Broccoli II plant cases. The recent ruling by the CJEU in the Seattle Genetics case on SPCs is discussed, and we give a European Biotech perspective on the new USPTO guidance in light of the Myriad, Prometheus and Alice decisions. In the field of software inventions, we review the latest edition of the EPO Examiner’s Guidelines and also report on a new “fallacy” for the assessment of inventive step. Our Trademark and Design professionals offer some sound advice to those choosing a name for their company.
Please let us know if you have any questions, comments or feedback by contacting us at email@example.com.
Thank you for taking the time to read our Newsletter!